Literature DB >> 16517767

Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.

Daniel B Brown1, Jean-Francois H Geschwind, Michael C Soulen, Steven F Millward, David Sacks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16517767     DOI： 10.1097/01.RVI.0000196277.76812.A3

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


× No keyword cloud information.
  32 in total

1.  Liver abscess as a complication of hepatic transarterial chemoembolization: a case report, literature review, and clinical recommendations.

Authors:  Ari M Vanderwalde; Howard Marx; Lucille Leong
Journal:  Gastrointest Cancer Res       Date:  2009-11

2.  Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.

Authors:  Ioannis T Konstantinidis; Bas Groot Koerkamp; Richard K G Do; Mithat Gönen; Yuman Fong; Peter J Allen; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; David S Klimstra; Nancy E Kemeny; William R Jarnagin
Journal:  Cancer       Date:  2015-12-22       Impact factor: 6.860

Review 3.  Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy.

Authors:  Andrew L Lewis; Matthew R Dreher
Journal:  J Control Release       Date:  2012-01-21       Impact factor: 9.776

4.  Liver abscess following transarterial chemoembolization.

Authors:  Danny Cheng
Journal:  Semin Intervent Radiol       Date:  2011-12       Impact factor: 1.513

5.  Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients.

Authors:  Tongmeng Yan; Linlin Lu; Cong Xie; Jiamei Chen; Xiaojuan Peng; Lijun Zhu; Ying Wang; Qiang Li; Jian Shi; Fuyuan Zhou; Ming Hu; Zhongqiu Liu
Journal:  Mol Cancer Ther       Date:  2015-10-29       Impact factor: 6.261

6.  Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.

Authors:  Zhijun Wang; Mingde Lin; David Lesage; Rongxin Chen; Julius Chapiro; Tara Gu; Vania Tacher; Rafael Duran; Jean-François Geschwind
Journal:  Acad Radiol       Date:  2014-03       Impact factor: 3.173

7.  Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma.

Authors:  Dingxin Wang; Ron C Gaba; Brian Jin; Ahsun Riaz; Robert J Lewandowski; Robert K Ryu; Kent T Sato; Ann B Ragin; Laura M Kulik; Mary F Mulcahy; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  Acad Radiol       Date:  2011-07       Impact factor: 3.173

8.  Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.

Authors:  Diane K Reyes; Josephina A Vossen; Ihab R Kamel; Nilofer S Azad; Tamara A Wahlin; Michael S Torbenson; Michael A Choti; Jean-Francois H Geschwind
Journal:  Cancer J       Date:  2009 Nov-Dec       Impact factor: 3.360

9.  Four-dimensional transcatheter intraarterial perfusion MR imaging for monitoring chemoembolization of hepatocellular carcinoma: preliminary results.

Authors:  Ron C Gaba; Dingxin Wang; Robert J Lewandowski; Robert K Ryu; Kent T Sato; Laura M Kulik; Mary F Mulcahy; Andrew C Larson; Riad Salem; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2008-09-25       Impact factor: 3.464

10.  Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry.

Authors:  Robert C G Martin; Jonathan Joshi; Ken Robbins; Dana Tomalty; Ryan O'Hara; Cliff Tatum
Journal:  J Oncol       Date:  2009-10-29       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.